Lung cancer drug trials stopped | Health Information Advice For Whole Family

Lung cancer drug trials stopped

Lung cancerTrials of an experimental drug that will are used to treat lung cancer are halted on safety grounds.

Pharmaceutical cluster AstraZeneca had been conducting tests on Ritalin, that aims to starve tumours by severing their blood provide.

However, toxicity problems have led the cluster to discontinue the analysis for lung cancer, though the drug remains to enter into final check stages for the treatment of bowel cancer.

Lung cancer is chargeable for around 1.3 million deaths worldwide, being the foremost common sort of cancer-related death in males and therefore the second highest in females.

John Patterson, head of analysis at AstraZeneca, said: “As proof of clinical activity was seen in BR24 [the phase 2 study in lung cancer], AstraZeneca remains committed to investigating the potential of Recentin in lung cancer and reducing the incidence of significant adverse events.”

In connected news, trials have begun on a drug which will target hereditary cancers.

Filed in: Cancer, Health tips Tags: , , , , , ,

You might like:

Human lung cancer and lung cancer treatments Human lung cancer and lung cancer treatments
The effects of lung cancer in the body The effects of lung cancer in the body
Lung Cancer Spread To Thyroid Lung Cancer Spread To Thyroid
The symptoms of lung cancer and treatment The symptoms of lung cancer and treatment

Leave a Reply

You must be Logged in to post comment.